The US Food and Drug Administration will be asked to approve MDMA to treat post-traumatic stress disorder by October — opening the door to the use of hallucinogenic drugs to treat mental illness.
If approved, the drug will be available in hospitals before the second half of next year, according to new research.
MDMA, also known as ecstasy or molly, is a popular drug in rave culture, with people taking it to connect with the music and dance the night away.
However, a 2021 clinical trial for the nonprofit organization Multidisciplinary Association for Psychedelic Studies showed that out of 90 people who suffered from post-traumatic stress disorder, those who took MDMA paired with psychotherapy were twice as likely to recover compared to those who did psychotherapy with a placebo, according to the journal Nature.
Read more at https://nypost.com/2023/04/21/mdma-expected-to-be-approved-to-treat-ptsd-by-october-study/
#fda #mdma #ptsd
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports: https://www.youtube.com/c/nypostsports
Catch the latest news here: https://nypost.com/
Follow The New York Post on:
Twitter – https://twitter.com/nypost
Facebook – https://www.facebook.com/NYPost